OQC has announced its ongoing $100m Series B, led by Japanese venture capital fund SBI Investment, in addition to existing investors Oxford Science Enterprises (OSE), University of Tokyo Edge Capital Partners (UTEC), and Lansdowne Partners.
The announcement is made alongside the launch of OQC Toshiko the Company’s powerful next generation 32-qubit platform, deployed to commercial data-centres, enabling businesses to tap into ground-breaking technology from anywhere in the world, seamlessly and securely.
OrganOx has raised £25m to continue the development and commercial rollout of metra, its fully automated normothermic perfusion (NMP) device for liver transplantation.
The round was led by external investor Lauxera Capital Partners, with support from existing investors.
Caristo Diagnostics has raised £13m to advance its CaRi-Heart® technology, an AI-assisted heart imaging tool capable of predicting risk of future heart attacks.
The round was led by Oxford Science Enterprises with participation from BGF, Longwall Venture Partners and Oxford University.
Mind Foundry, an Oxford University spinout that develops AI for high-stakes applications, has announced a continuation of their successful collaboration with the Aioi Nissay Dowa group.
The Aioi R&D Lab will focus on developing real-world AI solutions to major societal challenges through better insurance.
